TEL AVIV, Israel and ANDOVER, Mass., July 15, 2019 /PRNewswire/ -- MaxQ AI, the industry-leading medical diagnostic AI company, today announced the appointment of

FRANKFURT, Germany and SAN DIEGO and WASHINGTON, July 15, 2019 /PRNewswire/ -- KESSEL MEDintim, WCG Cares (WCG) and Population Services International (PSI) announced the launch of the Caya™ Diaphragm and Caya™ Gel in Niger.

WESTBROOK, Maine, July 15, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbi

WASHINGTON, July 15, 2019 /PRNewswire/ -- National and state government leaders, health agencies, patient advocacy groups, caregivers, local communities and individuals across the country recognized Chronic Disease Day on July 10 to raise awareness on what everyone can do to help prevent chronic conditions and support those with unpreventabl

DENVER, July 15, 2019 /PRNewswire/ -- Morris Animal Foundation-funded researchers at

FORT WORTH, Texas, July 15, 2019 /PRNewswire/ -- At Caregiver, Inc., 3500 employees fulfill myriad roles caring for individuals with intellectual or developmental disabilities (IDD) in four states

GOSSELIES, Belgium and LEIDEN, Netherlands, July 15, 2019 /PRNewswire/ -- Ncardia announced today that following retraction of the Cor.4U product line from the market and resulting insolvency of its former legal entity in Germany (operating under the name Ncardia AG / former Axiogenesis), it has accel

MOUNTAIN VIEW, Calif., July 15, 2019 /PRNewswire/ -- Nearly 60 percent of Minnesota survey respondents received a medical bill that came as a surprise or was difficult to pay off, according to the first-ever Minnesota Resident Medical Debt Survey by

GREENWOOD VILLAGE, Colo., July 15, 2019 /PRNewswire/ -- The Steven A. Cohen Military Family Clinic at University of Colorado Anschutz Medical Campus announces that U.S. Marine Corps veteran Kammy Bishop, LPC, CAC II is appointed as the new clinic director. Bishop will oversee all clinical operations at the c

ABBOTT PARK, Ill., July 15, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the company has received U.S. Food and Drug Administration (FDA) approval for the most advanced MitraClip™ heart valve repair device to treat mitral regurgitation. The latest approval for the fourth-generation MitraClip device, MitraClip G4, puts new enhancements into the hands of physicians across the U